Page last updated: 2024-10-24

busulfan and Hepatitis, Viral, Human

busulfan has been researched along with Hepatitis, Viral, Human in 1 studies

Hepatitis, Viral, Human: INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D).

Research Excerpts

ExcerptRelevanceReference
" The conditioning regimen was cyclophosphamide (160 mg/kg) and busulfan (10-14 mg/kg), followed by unmanipulated bone marrow (median of 5&10(8) cells/kg) and CyA (+MTX in two patients) for prophylaxis of graft-versus-host disease (GvHD)."5.09Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria. ( Bacigalupo, A; Benvenuto, F; Berisso, G; Bregante, S; Figari, O; Frassoni, F; Gualandi, F; Lamparelli, T; Mordini, N; Raiola, AM; Van Lint, MT, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raiola, AM1
Van Lint, MT1
Lamparelli, T1
Gualandi, F1
Benvenuto, F1
Figari, O1
Mordini, N1
Berisso, G1
Bregante, S1
Frassoni, F1
Bacigalupo, A1

Trials

1 trial available for busulfan and Hepatitis, Viral, Human

ArticleYear
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria.
    Haematologica, 2000, Volume: 85, Issue:1

    Topics: Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Female; Follow-Up Studies; Graft Sur

2000